Verano Holdings (VRNO) FCF Margin (QoQ) (2021 - 2026)
Verano Holdings (VRNO) FCF Margin (QoQ) (2021 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.38 Bn | 43.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.73 Bn | 40.08 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.76 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn |
| 6 | Viatris | 18.94 Bn | 18.05 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.54 Bn | 15.15 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.01 Bn | 11.48 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.98 Bn | - |
| 10 | Verano Holdings | 443.93 Mn | 358.74 Mn | 99.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 685.00 |
| Mar 31, 2026 | -37.00 |
| Dec 31, 2025 | -720.00 |
| Sep 30, 2025 | 910.00 |
| Jun 30, 2025 | 597.00 |
| Mar 31, 2025 | -1,916.00 |
| Dec 31, 2024 | 2,580.00 |
| Sep 30, 2024 | -763.00 |
| Jun 30, 2024 | -250,383.00 |
| Mar 31, 2024 | 247,632.00 |
| Dec 31, 2023 | 1,164.00 |
| Sep 30, 2023 | 432.00 |
| Jun 30, 2023 | 313.00 |
| Mar 31, 2023 | -5,510.00 |
| Dec 31, 2022 | 9,600.00 |
| Sep 30, 2022 | -6,147.00 |
| Jun 30, 2022 | 3,108.00 |
| Mar 31, 2022 | -1,332.00 |
| Dec 31, 2021 | -943.00 |